“…As can be seen in Table 1, these results of hypofractionated treatment described above, which is consistent with an α/β The comparable freedom from biochemical failure (FFBF) rates and moderate toxicity of increasingly hypofractionated results support a low α/β ratio and the use of even higher doses per fraction fx Fractions, int intermediate, EQD equivalent dose at 1.8 Gy per fraction, assuming an α/β of 1.5 Gy, NS not specified, NSBD not specified by dose ratio of 1.5 Gy. That is, if the α/β ratio were significantly higher than 1.5 Gy, then hypofractionated studies [16][17][18]20] would have EQD1.8's below 70 Gy, which contradicts their comparable outcomes to conventional fractionation delivery at 81 Gy.…”